Pure Biologics Spólka Akcyjna (PUR) — Capital Reinvestment Ratio
Pure Biologics Spólka Akcyjna (PUR) has a Capital Reinvestment Ratio of 0.04x as of March 2024, meaning it reinvests 0% of its operating cash flow (zł2.04 Million) in capital expenditures (zł85.00K). See PUR net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pure Biologics Spólka Akcyjna Capital Reinvestment Ratio (2019–2019)
This chart tracks Pure Biologics Spólka Akcyjna's Capital Reinvestment Ratio across 1 annual periods. Check Pure Biologics Spólka Akcyjna (PUR) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pure Biologics Spólka Akcyjna (2019–2019)
Year-by-year Capital Reinvestment Ratio for Pure Biologics Spólka Akcyjna from 2019 to 2019. For live market cap and broader valuation context, see market value of Pure Biologics Spólka Akcyjna.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | zł5.33 Million | zł161.92K | — |